Connection

Libby Infinger to Histone Deacetylase Inhibitors

This is a "connection" page, showing publications Libby Infinger has written about Histone Deacetylase Inhibitors.
  1. Single agent efficacy of the HDAC inhibitor DATS in preclinical models of glioblastoma. Cancer Chemother Pharmacol. 2018 12; 82(6):945-952.
    View in: PubMed
    Score: 0.139
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.